Agios Pharmaceuticals: 2Q Earnings Snapshot

August 2, 2018

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $68.7 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.19 per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.62 per share.

The biopharmaceutical company posted revenue of $40.4 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $12.1 million.

Agios Pharmaceuticals shares have increased 52 percent since the beginning of the year. The stock has risen 48 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO

Update hourly